Literature DB >> 19423181

Denial and physical outcomes in lung cancer patients, a longitudinal study.

Martina S Vos1, Hein Putter, Hans C van Houwelingen, Hanneke C J M de Haes.   

Abstract

Although denial in cancer patients is often seen in clinical practice, studies relating denial to physical outcomes are lacking. The present study aims to investigate patterns of denial among lung cancer patients and connect these to their physical outcomes. Denial was measured longitudinally in 195 consecutive newly diagnosed lung cancer patients. Four assessments were conducted over an 8-month period. Patient-reported physical outcomes were measured with a generic and disease-specific quality of life measure. Medical data were provided by the patients' chest physicians. Three patterns of denial over time were identified in lung cancer patients: patients displayed either low, moderate or increasing denial. Male lung cancer patients were found to deny at a moderate level more often. A moderate or increasing level of denial was consistently related to improved patient-rated physical outcomes. Lung cancer patients displaying more denial reported a better overall perception of health and better physical functioning. They complained less about fatigue, nausea and vomiting, appetite loss, dysphagia and pain in arm and shoulder than low deniers. Other symptoms did not differ among denial classes. Denial in lung cancer patients may well be an adaptive mechanism and have to be respected in clinical practice. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19423181     DOI: 10.1016/j.lungcan.2009.04.003

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  4 in total

1.  The meaning of parenteral hydration to family caregivers and patients with advanced cancer receiving hospice care.

Authors:  Marlene Z Cohen; Isabel Torres-Vigil; Beth E Burbach; Allison de la Rosa; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2012-03-27       Impact factor: 3.612

2.  Development of an intervention to support patients and clinicians with advanced lung cancer when considering systematic anticancer therapy: protocol for the PACT study.

Authors:  Despina Anagnostou; Stephanie Sivell; Simon Noble; Jason Lester; Anthony Byrne; Catherine Sampson; Mirella Longo; Annmarie Nelson
Journal:  BMJ Open       Date:  2017-07-12       Impact factor: 2.692

3.  The value of immunotherapy for survivors of stage IV non-small cell lung cancer: patient perspectives on quality of life.

Authors:  Rebekah Park; James W Shaw; Alix Korn; Jacob McAuliffe
Journal:  J Cancer Surviv       Date:  2020-01-16       Impact factor: 4.442

4.  Coping strategies of patients with advanced lung or colorectal cancer in six European countries: Insights from the ACTION Study.

Authors:  Lea J Jabbarian; Ida J Korfage; Branka Červ; Johannes J M van Delden; Luc Deliens; Guido Miccinesi; Sheila Payne; Anna Thit Johnsen; Mariëtte N Verkissen; Andrew Wilcock; Agnes van der Heide; Judith A C Rietjens
Journal:  Psychooncology       Date:  2019-11-20       Impact factor: 3.894

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.